SIM
IGMS

Spark Investment Management’s IGM Biosciences IGMS Stock Holding History

Spark Investment Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,000
Closed -$393K – 162
2020
Q1 		$393K Buy
+7,000
New +$307K 0.21% 156

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Spark Investment Management's IGMS Position: Q2 2020 in Review

Spark Investment Management sold out of IGM Biosciences (IGMS) in Q2 2020, closing a stake of 7,000 shares — an estimated $393K sold.

Spark Investment Management first reported a position in IGMS in Q1 2020 and held it in 1 quarter. The position peaked at $393K in Q1 2020. 81 funds tracked by Wall St. Rank hold IGMS as of Q2 2020.

  • Spark Investment Management reported no remaining IGM Biosciences position as of Q2 2020 after selling out during the quarter.
  • Spark Investment Management sold 7,000 IGM Biosciences shares in Q2 2020, an estimated $393K.
  • Spark Investment Management first reported a position in IGM Biosciences in Q1 2020 and held it in 1 quarter.
  • Spark Investment Management's IGM Biosciences position peaked at $393K in Q1 2020.
  • 81 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.